Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid

Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In...

Full description

Saved in:
Bibliographic Details
Published inVirology journal Vol. 12; no. 1; p. 95
Main Authors Zhang, Xiangmin, Curtiss, Roy
Format Journal Article
LanguageEnglish
Published London BioMed Central 22.06.2015
BioMed Central Ltd
Subjects
Online AccessGet full text
ISSN1743-422X
1743-422X
DOI10.1186/s12985-015-0321-5

Cover

Abstract Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. Results A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10 5 –10 6 50 % tissue culture infective dose (TCID 50 )/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. Conclusions An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus.
AbstractList The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10.sup.5-10.sup.6 50 % tissue culture infective dose (TCID.sub.50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus.
The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10(5)-10(6) 50% tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus.
The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus.BACKGROUNDThe current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus.A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10(5)-10(6) 50% tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method.RESULTSA plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10(5)-10(6) 50% tissue culture infective dose (TCID50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method.An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus.CONCLUSIONSAn all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus.
Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. Results A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10.sup.5-10.sup.6 50 % tissue culture infective dose (TCID.sub.50)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin-Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. Conclusions An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust "1 + 2" approach to generate influenza vaccine seed virus. Keywords: Influenza virus, Reverse genetics, Mouse RNA polymerase I promoter
Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. Results A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10 5 –10 6 50 % tissue culture infective dose (TCID 50 )/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. Conclusions An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus.
BACKGROUND: The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be cost-effective to immunize huge flocks of birds. We propose a novel influenza vaccine composing a bacterial carrier and a plasmid cargo. In the immunized subjects, the bacterial carrier invades and releases its cargo into host cells where the plasmid expresses viral RNAs and proteins for reconstitution of attenuated influenza virus. Here we aimed to construct a mouse PolI-driven plasmid for efficient production of influenza virus. RESULTS: A plasmid was constructed to express all influenza viral RNAs and proteins. This all-in-one plasmid resulted in 10⁵–10⁶ 50 % tissue culture infective dose (TCID₅₀)/mL of influenza A virus in baby hamster kidney (BHK-21) cells on the third day post-transfection, and also reconstituted influenza virus in Madin–Darby canine kidney (MDCK) and Chinese hamster ovary (CHO) cells. A 6-unit plasmid was constructed by deleting the HA and NA cassettes from the all-in-one plasmid. Cotransfection of BHK-21 cells with the 6-unit plasmid and the two other plasmids encoding the HA or NA genes resulted in influenza virus titers similar to those produced by the 1-plasmid method. CONCLUSIONS: An all-in-one plasmid and a 3-plasmid murine PolI-driven reverse genetics systems were developed, and efficiently reconstituted influenza virus in BHK-21 cells. The all-in-one plasmid may serve as a tool to determine the factors inhibiting virus generation from a large size plasmid. In addition, we recommend a simple and robust “1 + 2” approach to generate influenza vaccine seed virus.
ArticleNumber 95
Audience Academic
Author Curtiss, Roy
Zhang, Xiangmin
Author_xml – sequence: 1
  givenname: Xiangmin
  surname: Zhang
  fullname: Zhang, Xiangmin
  organization: Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, Department of Pharmaceutical Sciences, Eugene Applebaum College of Pharmacy/Health Sciences, Wayne State University
– sequence: 2
  givenname: Roy
  surname: Curtiss
  fullname: Curtiss, Roy
  email: rcurtiss@ufl.edu
  organization: Center for Infectious Diseases and Vaccinology, The Biodesign Institute, Arizona State University, School of Life Science, Arizona State University, Department of Infectious Diseases and Pathology, College of Veterinary Medicine, University of Florida
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26093583$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1rFDEYhQep2Hb1B3gjAW_qxdR8TDKZG2EpVReKQlXwLmQzyTYlk6zJzGr99b7rttIVqYSQr-e8SQ7nuDqIKdqqek7wKSFSvC6EdpLXmEBnlNT8UXVE2obVDaVfD-7ND6vjUq4xQKLtnlSHVOCOccmOKnXunDfexhGtbLRZjz5FlBzy0YXJxp8abXyeCvruxyuk0ZCmYtHlhzlap3AzgACWi7rPfmMj0iHUPtbwSrQOugy-f1o9djoU--x2nFVf3p5_PntfX3x8tzibX9RGNGKsqesJE3LpOi7o0rQGY0t7TESvHV9Szg3hWBreSswIwYY6wozAfGkEkw1v2ax6s6u7npaD7Q18KOug1tkPOt-opL3aP4n-Sq3SRjVNx1twY1ad3BbI6dtky6gGX4wNQUcLf1aMcCbalnf4vygRHSeSNrwB9OUOXelgFXia4HKzxdWcN4RTSaUE6vQfFLTeDt6Am87D_p7g1Z4AmNH-GFd6KkUtPl3usy_uO_PHkrsMANDuAJNTKdk6Zfz4OwfwCh8UwWqbNrVLm4K0qW3aFAcl-Ut5V_whDd1pCrBxZbO6TlOOkI0HRL8A6rrkJQ
CitedBy_id crossref_primary_10_1016_j_jviromet_2017_08_024
crossref_primary_10_3390_v9110332
crossref_primary_10_3390_v8060119
crossref_primary_10_4049_jimmunol_1600608
crossref_primary_10_1016_j_virol_2017_06_003
crossref_primary_10_1073_pnas_1700738114
crossref_primary_10_1016_j_vaccine_2016_07_010
crossref_primary_10_2217_fvl_2017_0046
crossref_primary_10_1021_acssynbio_3c00526
crossref_primary_10_1021_acssynbio_2c00358
crossref_primary_10_1146_annurev_virology_111821_120445
crossref_primary_10_1007_s11262_017_1457_8
crossref_primary_10_1016_j_nbt_2023_08_001
crossref_primary_10_1007_s12250_018_0066_6
crossref_primary_10_3390_ijms18010020
crossref_primary_10_1101_cshperspect_a038547
Cites_doi 10.1099/vir.0.82452-0
10.1128/JVI.78.22.12683-12688.2004
10.1093/nar/27.19.3792
10.1007/BF00272905
10.1128/JVI.01468-14
10.1016/S1366-2120(07)70016-8
10.1128/JVI.73.11.9679-9682.1999
10.1099/0022-1317-81-12-2843
10.1016/j.vaccine.2006.03.012
10.1016/j.virol.2005.10.005
10.1128/JVI.01876-07
10.1093/emboj/16.6.1248
10.1073/pnas.1120265109
10.1016/j.virusres.2013.05.006
10.1086/507544
10.1002/btpr.2038
10.1128/JVI.70.6.4188-4192.1996
10.1128/JVI.01925-09
10.1016/S0042-6822(02)00035-1
10.1007/BF00353939
10.1073/pnas.100133697
10.1038/nature04378
10.1128/JVI.63.12.5142-5152.1989
10.1016/0959-437X(95)80035-2
10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
10.3201/eid1201.051043
10.1016/j.vaccine.2009.02.064
10.1186/1743-422X-4-102
10.1016/j.vaccine.2004.08.054
10.1073/pnas.0505587102
10.1186/1471-2180-11-31
10.1128/JVI.01705-10
10.1073/pnas.96.16.9345
10.1016/0042-6822(88)90574-0
10.1016/S0264-410X(03)00071-9
10.1099/vir.0.051284-0
10.1007/BF00330768
10.1016/0092-8674(89)90766-6
10.1093/nar/21.16.3607
10.1128/JVI.79.21.13811-13816.2005
10.1128/JVI.00781-09
10.1128/JVI.02014-13
10.1007/s00253-011-3758-5
10.1371/journal.pone.0119041
10.1006/viro.1994.1365
10.1006/viro.1999.9892
10.1006/viro.2001.1008
ContentType Journal Article
Copyright Zhang and Curtiss. 2015
COPYRIGHT 2015 BioMed Central Ltd.
Copyright_xml – notice: Zhang and Curtiss. 2015
– notice: COPYRIGHT 2015 BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
7X8
7S9
L.6
5PM
DOI 10.1186/s12985-015-0321-5
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic



AGRICOLA
Database_xml – sequence: 1
  dbid: C6C
  name: SpringerOpen Free (Free internet resource, activated by CARLI)
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1743-422X
EndPage 95
ExternalDocumentID PMC4495709
A541528288
26093583
10_1186_s12985_015_0321_5
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI065779
– fundername: NIAID NIH HHS
  grantid: AI065779
GroupedDBID ---
0R~
123
29Q
2WC
4.4
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAHBH
AAJSJ
AASML
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-c646t-2fd1368bf9562bc7c00e2d016daf5b255c1508c57803110c2f13c605bc6384573
IEDL.DBID M48
ISSN 1743-422X
IngestDate Thu Aug 21 17:38:57 EDT 2025
Fri Sep 05 15:03:26 EDT 2025
Thu Sep 04 19:09:30 EDT 2025
Tue Jun 17 22:07:12 EDT 2025
Tue Jun 10 21:10:19 EDT 2025
Fri Jun 27 05:58:56 EDT 2025
Thu Apr 03 07:00:46 EDT 2025
Tue Jul 01 01:44:41 EDT 2025
Thu Apr 24 22:59:47 EDT 2025
Sat Sep 06 07:30:06 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Mouse RNA polymerase I promoter
Influenza virus
Reverse genetics
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c646t-2fd1368bf9562bc7c00e2d016daf5b255c1508c57803110c2f13c605bc6384573
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12985-015-0321-5
PMID 26093583
PQID 1695182454
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4495709
proquest_miscellaneous_3153677590
proquest_miscellaneous_1695182454
gale_infotracmisc_A541528288
gale_infotracacademiconefile_A541528288
gale_incontextgauss_ISR_A541528288
pubmed_primary_26093583
crossref_citationtrail_10_1186_s12985_015_0321_5
crossref_primary_10_1186_s12985_015_0321_5
springer_journals_10_1186_s12985_015_0321_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-06-22
PublicationDateYYYYMMDD 2015-06-22
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-22
  day: 22
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Virology journal
PublicationTitleAbbrev Virol J
PublicationTitleAlternate Virol J
PublicationYear 2015
Publisher BioMed Central
BioMed Central Ltd
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
References HF Maassab (321_CR22) 1999; 9
E Fodor (321_CR10) 1999; 73
P Suphaphiphat (321_CR45) 2010; 84
T Noda (321_CR1) 2006; 439
H Kallel (321_CR29) 2006; 24
C Sieben (321_CR37) 2012; 109
Z Wang (321_CR15) 2007; 4
M Baz (321_CR40) 2013; 178
KG Murti (321_CR2) 1988; 164
SL Londrigan (321_CR41) 2011; 85
G Neumann (321_CR9) 1999; 96
K Klumpp (321_CR3) 1997; 16
S Pleschka (321_CR8) 1996; 70
P Massin (321_CR16) 2005; 79
J Heix (321_CR13) 1995; 5
OW Merten (321_CR33) 1999; 98
EA Govorkova (321_CR32) 1999; 262
A Zobel (321_CR7) 1993; 21
P Reculard (321_CR30) 1996
W Luytjes (321_CR5) 1989; 59
JY Kim (321_CR31) 2012; 93
A Laban (321_CR46) 1981; 184
KL Nichol (321_CR35) 2006; 194
X Zhang (321_CR28) 2015; 10
N Lin (321_CR43) 2015; 31
L Monaco (321_CR38) 1996; 22
E Wit de (321_CR17) 2007; 88
X Zhang (321_CR19) 2009; 83
F Almazan (321_CR34) 2004; 78
WC Ng (321_CR42) 2014; 88
PD Minor (321_CR27) 2009; 27
E Hoffmann (321_CR11) 2000; 81
H Jin (321_CR26) 2003; 306
MS Song (321_CR44) 2013; 94
PS Hartman (321_CR48) 1991; 11
G Neumann (321_CR21) 2001; 287
JD Parvin (321_CR4) 1989; 63
E Hoffmann (321_CR12) 2000; 97
H Chen (321_CR20) 2014; 88
Z Chen (321_CR24) 2006; 345
G Neumann (321_CR6) 1994; 202
P Kreiss (321_CR36) 1999; 27
G Neumann (321_CR18) 2005; 102
P Palese (321_CR39) 2006; 12
X Zhang (321_CR50) 2011; 11
C Nicolson (321_CR23) 2005; 23
C Gerdil (321_CR25) 2003; 21
S Murakami (321_CR14) 2008; 82
M Matfield (321_CR47) 1985; 199
KN Rand (321_CR49) 1996; 1
11531402 - Virology. 2001 Sep 1;287(2):243-50
2598262 - Cell. 1989 Dec 22;59(6):1107-13
8664554 - Curr Opin Genet Dev. 1995 Oct;5(5):652-6
1809328 - Biotechniques. 1991 Dec;11(6):747-8
15507657 - J Virol. 2004 Nov;78(22):12683-8
22869709 - Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13626-31
17163383 - J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8
21191006 - J Virol. 2011 Mar;85(6):2990-3000
16600442 - Vaccine. 2006 May 29;24(22):4856-62
3369093 - Virology. 1988 Jun;164(2):562-6
10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50
12620793 - Virology. 2003 Feb 1;306(1):18-24
24942589 - J Virol. 2014 Sep 1;88(17):10013-25
16494719 - Emerg Infect Dis. 2006 Jan;12(1):61-5
8648766 - J Virol. 1996 Jun;70(6):4188-92
10801978 - Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
16227302 - J Virol. 2005 Nov;79(21):13811-6
20071567 - J Virol. 2010 Apr;84(7):3721-5
10489338 - Virology. 1999 Sep 15;262(1):31-8
24257596 - J Virol. 2014 Feb;88(3):1659-72
23726847 - Virus Res. 2013 Dec 5;178(1):78-98
16267134 - Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16825-9
18045936 - J Virol. 2008 Feb;82(3):1605-9
15780743 - Vaccine. 2005 Apr 22;23(22):2943-52
22159888 - Appl Microbiol Biotechnol. 2012 Feb;93(3):917-30
10481017 - Nucleic Acids Res. 1999 Oct 1;27(19):3792-8
11086114 - J Gen Virol. 2000 Dec;81(Pt 12):2843-7
23486669 - J Gen Virol. 2013 Jun;94(Pt 6):1230-5
10578119 - Rev Med Virol. 1999 Oct-Dec;9(4):237-44
7035834 - Mol Gen Genet. 1981;184(2):200-7
8009859 - Virology. 1994 Jul;202(1):477-9
16289204 - Virology. 2006 Feb 20;345(2):416-23
2993800 - Mol Gen Genet. 1985;199(3):518-23
25641927 - Biotechnol Prog. 2015 Mar-Apr;31(2):334-46
10516084 - J Virol. 1999 Nov;73(11):9679-82
19366582 - Vaccine. 2009 May 14;27(22):2907-13
16437116 - Nature. 2006 Jan 26;439(7075):490-2
22358930 - Cytotechnology. 1996 Jan;22(1-3):197-203
12686093 - Vaccine. 2003 May 1;21(16):1776-9
10494957 - Dev Biol Stand. 1999;98:23-37; discussion 73-4
8367275 - Nucleic Acids Res. 1993 Aug 11;21(16):3607-14
17956624 - Virol J. 2007;4:102
17374773 - J Gen Virol. 2007 Apr;88(Pt 4):1281-7
19587040 - J Virol. 2009 Sep;83(18):9296-303
2585601 - J Virol. 1989 Dec;63(12):5142-52
25742162 - PLoS One. 2015;10(3):e0119041
9135141 - EMBO J. 1997 Mar 17;16(6):1248-57
21303535 - BMC Microbiol. 2011;11:31
References_xml – volume: 88
  start-page: 1281
  year: 2007
  ident: 321_CR17
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.82452-0
– volume: 78
  start-page: 12683
  year: 2004
  ident: 321_CR34
  publication-title: J Virol
  doi: 10.1128/JVI.78.22.12683-12688.2004
– volume: 27
  start-page: 3792
  year: 1999
  ident: 321_CR36
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/27.19.3792
– volume: 184
  start-page: 200
  year: 1981
  ident: 321_CR46
  publication-title: Mol Gen Genet
  doi: 10.1007/BF00272905
– volume: 88
  start-page: 10013
  year: 2014
  ident: 321_CR20
  publication-title: J Virol
  doi: 10.1128/JVI.01468-14
– volume: 1
  start-page: 23
  year: 1996
  ident: 321_CR49
  publication-title: Tech Tips Online
  doi: 10.1016/S1366-2120(07)70016-8
– volume: 73
  start-page: 9679
  year: 1999
  ident: 321_CR10
  publication-title: J Virol
  doi: 10.1128/JVI.73.11.9679-9682.1999
– volume: 81
  start-page: 2843
  year: 2000
  ident: 321_CR11
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-81-12-2843
– volume: 24
  start-page: 4856
  year: 2006
  ident: 321_CR29
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.03.012
– volume: 345
  start-page: 416
  year: 2006
  ident: 321_CR24
  publication-title: Virology
  doi: 10.1016/j.virol.2005.10.005
– volume: 82
  start-page: 1605
  year: 2008
  ident: 321_CR14
  publication-title: J Virol
  doi: 10.1128/JVI.01876-07
– volume: 16
  start-page: 1248
  year: 1997
  ident: 321_CR3
  publication-title: EMBO J
  doi: 10.1093/emboj/16.6.1248
– volume: 109
  start-page: 13626
  year: 2012
  ident: 321_CR37
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1120265109
– volume: 178
  start-page: 78
  year: 2013
  ident: 321_CR40
  publication-title: Virus Res
  doi: 10.1016/j.virusres.2013.05.006
– volume: 194
  start-page: S111
  issue: Suppl 2
  year: 2006
  ident: 321_CR35
  publication-title: J Infect Dis
  doi: 10.1086/507544
– volume: 31
  start-page: 334
  year: 2015
  ident: 321_CR43
  publication-title: Biotechnol Prog
  doi: 10.1002/btpr.2038
– volume: 70
  start-page: 4188
  year: 1996
  ident: 321_CR8
  publication-title: J Virol
  doi: 10.1128/JVI.70.6.4188-4192.1996
– volume: 84
  start-page: 3721
  year: 2010
  ident: 321_CR45
  publication-title: J Virol
  doi: 10.1128/JVI.01925-09
– volume: 11
  start-page: 747
  year: 1991
  ident: 321_CR48
  publication-title: Biotechniques
– volume: 306
  start-page: 18
  year: 2003
  ident: 321_CR26
  publication-title: Virology
  doi: 10.1016/S0042-6822(02)00035-1
– volume: 22
  start-page: 197
  year: 1996
  ident: 321_CR38
  publication-title: Cytotechnology
  doi: 10.1007/BF00353939
– volume: 97
  start-page: 6108
  year: 2000
  ident: 321_CR12
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.100133697
– start-page: 314
  volume-title: Laboratory techniques in rabies
  year: 1996
  ident: 321_CR30
– volume: 439
  start-page: 490
  year: 2006
  ident: 321_CR1
  publication-title: Nature
  doi: 10.1038/nature04378
– volume: 63
  start-page: 5142
  year: 1989
  ident: 321_CR4
  publication-title: J Virol
  doi: 10.1128/JVI.63.12.5142-5152.1989
– volume: 5
  start-page: 652
  year: 1995
  ident: 321_CR13
  publication-title: Curr Opin Genet Dev
  doi: 10.1016/0959-437X(95)80035-2
– volume: 9
  start-page: 237
  year: 1999
  ident: 321_CR22
  publication-title: Rev Med Virol
  doi: 10.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
– volume: 12
  start-page: 61
  year: 2006
  ident: 321_CR39
  publication-title: Emerg Infect Dis
  doi: 10.3201/eid1201.051043
– volume: 27
  start-page: 2907
  year: 2009
  ident: 321_CR27
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2009.02.064
– volume: 4
  start-page: 102
  year: 2007
  ident: 321_CR15
  publication-title: Virol J
  doi: 10.1186/1743-422X-4-102
– volume: 23
  start-page: 2943
  year: 2005
  ident: 321_CR23
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2004.08.054
– volume: 102
  start-page: 16825
  year: 2005
  ident: 321_CR18
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0505587102
– volume: 11
  start-page: 31
  year: 2011
  ident: 321_CR50
  publication-title: BMC Microbiol
  doi: 10.1186/1471-2180-11-31
– volume: 85
  start-page: 2990
  year: 2011
  ident: 321_CR41
  publication-title: J Virol
  doi: 10.1128/JVI.01705-10
– volume: 98
  start-page: 23
  year: 1999
  ident: 321_CR33
  publication-title: Dev Biol Stand
– volume: 96
  start-page: 9345
  year: 1999
  ident: 321_CR9
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.96.16.9345
– volume: 164
  start-page: 562
  year: 1988
  ident: 321_CR2
  publication-title: Virology
  doi: 10.1016/0042-6822(88)90574-0
– volume: 21
  start-page: 1776
  year: 2003
  ident: 321_CR25
  publication-title: Vaccine
  doi: 10.1016/S0264-410X(03)00071-9
– volume: 94
  start-page: 1230
  year: 2013
  ident: 321_CR44
  publication-title: J Gen Virol
  doi: 10.1099/vir.0.051284-0
– volume: 199
  start-page: 518
  year: 1985
  ident: 321_CR47
  publication-title: Mol Gen Genet
  doi: 10.1007/BF00330768
– volume: 59
  start-page: 1107
  year: 1989
  ident: 321_CR5
  publication-title: Cell
  doi: 10.1016/0092-8674(89)90766-6
– volume: 21
  start-page: 3607
  year: 1993
  ident: 321_CR7
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/21.16.3607
– volume: 79
  start-page: 13811
  year: 2005
  ident: 321_CR16
  publication-title: J Virol
  doi: 10.1128/JVI.79.21.13811-13816.2005
– volume: 83
  start-page: 9296
  year: 2009
  ident: 321_CR19
  publication-title: J Virol
  doi: 10.1128/JVI.00781-09
– volume: 88
  start-page: 1659
  year: 2014
  ident: 321_CR42
  publication-title: J Virol
  doi: 10.1128/JVI.02014-13
– volume: 93
  start-page: 917
  year: 2012
  ident: 321_CR31
  publication-title: Appl Microbiol Biotechnol
  doi: 10.1007/s00253-011-3758-5
– volume: 10
  start-page: e0119041
  year: 2015
  ident: 321_CR28
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0119041
– volume: 202
  start-page: 477
  year: 1994
  ident: 321_CR6
  publication-title: Virology
  doi: 10.1006/viro.1994.1365
– volume: 262
  start-page: 31
  year: 1999
  ident: 321_CR32
  publication-title: Virology
  doi: 10.1006/viro.1999.9892
– volume: 287
  start-page: 243
  year: 2001
  ident: 321_CR21
  publication-title: Virology
  doi: 10.1006/viro.2001.1008
– reference: 16600442 - Vaccine. 2006 May 29;24(22):4856-62
– reference: 25742162 - PLoS One. 2015;10(3):e0119041
– reference: 10430945 - Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9345-50
– reference: 25641927 - Biotechnol Prog. 2015 Mar-Apr;31(2):334-46
– reference: 2993800 - Mol Gen Genet. 1985;199(3):518-23
– reference: 21303535 - BMC Microbiol. 2011;11:31
– reference: 9135141 - EMBO J. 1997 Mar 17;16(6):1248-57
– reference: 10578119 - Rev Med Virol. 1999 Oct-Dec;9(4):237-44
– reference: 17956624 - Virol J. 2007;4:102
– reference: 10494957 - Dev Biol Stand. 1999;98:23-37; discussion 73-4
– reference: 2598262 - Cell. 1989 Dec 22;59(6):1107-13
– reference: 16267134 - Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16825-9
– reference: 8648766 - J Virol. 1996 Jun;70(6):4188-92
– reference: 19366582 - Vaccine. 2009 May 14;27(22):2907-13
– reference: 24257596 - J Virol. 2014 Feb;88(3):1659-72
– reference: 16494719 - Emerg Infect Dis. 2006 Jan;12(1):61-5
– reference: 11086114 - J Gen Virol. 2000 Dec;81(Pt 12):2843-7
– reference: 19587040 - J Virol. 2009 Sep;83(18):9296-303
– reference: 11531402 - Virology. 2001 Sep 1;287(2):243-50
– reference: 18045936 - J Virol. 2008 Feb;82(3):1605-9
– reference: 23486669 - J Gen Virol. 2013 Jun;94(Pt 6):1230-5
– reference: 10801978 - Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
– reference: 16289204 - Virology. 2006 Feb 20;345(2):416-23
– reference: 1809328 - Biotechniques. 1991 Dec;11(6):747-8
– reference: 2585601 - J Virol. 1989 Dec;63(12):5142-52
– reference: 10489338 - Virology. 1999 Sep 15;262(1):31-8
– reference: 17374773 - J Gen Virol. 2007 Apr;88(Pt 4):1281-7
– reference: 20071567 - J Virol. 2010 Apr;84(7):3721-5
– reference: 7035834 - Mol Gen Genet. 1981;184(2):200-7
– reference: 3369093 - Virology. 1988 Jun;164(2):562-6
– reference: 22869709 - Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13626-31
– reference: 12620793 - Virology. 2003 Feb 1;306(1):18-24
– reference: 8664554 - Curr Opin Genet Dev. 1995 Oct;5(5):652-6
– reference: 22159888 - Appl Microbiol Biotechnol. 2012 Feb;93(3):917-30
– reference: 15507657 - J Virol. 2004 Nov;78(22):12683-8
– reference: 8009859 - Virology. 1994 Jul;202(1):477-9
– reference: 12686093 - Vaccine. 2003 May 1;21(16):1776-9
– reference: 10516084 - J Virol. 1999 Nov;73(11):9679-82
– reference: 10481017 - Nucleic Acids Res. 1999 Oct 1;27(19):3792-8
– reference: 17163383 - J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8
– reference: 24942589 - J Virol. 2014 Sep 1;88(17):10013-25
– reference: 16227302 - J Virol. 2005 Nov;79(21):13811-6
– reference: 16437116 - Nature. 2006 Jan 26;439(7075):490-2
– reference: 15780743 - Vaccine. 2005 Apr 22;23(22):2943-52
– reference: 23726847 - Virus Res. 2013 Dec 5;178(1):78-98
– reference: 8367275 - Nucleic Acids Res. 1993 Aug 11;21(16):3607-14
– reference: 22358930 - Cytotechnology. 1996 Jan;22(1-3):197-203
– reference: 21191006 - J Virol. 2011 Mar;85(6):2990-3000
SSID ssj0032679
Score 2.1728234
Snippet Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to...
The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to be...
Background The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to...
BACKGROUND: The current influenza vaccines are effective against seasonal influenza, but cannot be manufactured in a timely manner for a sudden pandemic or to...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 95
SubjectTerms Animals
Antigens, Viral - biosynthesis
Antigens, Viral - genetics
Biomedical and Life Sciences
Biomedicine
CHO Cells
cost effectiveness
Cricetulus
Cricetulus griseus
DNA-directed RNA polymerase
Dogs
Epidemics
Genetic aspects
hamsters
Influenza
Influenza A virus
Influenza vaccines
Influenza Vaccines - genetics
Influenza Vaccines - immunology
Influenza viruses
kidneys
Madin Darby Canine Kidney Cells
Mice
Orthomyxoviridae - genetics
pandemic
Physiological aspects
Plasmids
Proteins
reverse genetics
Reverse Genetics - methods
RNA
RNA Polymerase I - metabolism
RNA, Viral - biosynthesis
RNA, Viral - genetics
tissue culture
Vaccines, Attenuated - genetics
Vaccines, Attenuated - immunology
Virology
viruses
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB-0ovgiWrVGW1lFEJTFJPuRvcfjaGmF9qFa6Nuy2U1q4Jo7LndC_eudSXJHc1ihD3kIO0nIzvfO7m8APgVqayQSwYVUgUshUee0y7kOLk-CScrC0Nnh0zN9fCG_X6rLHiyazsLcrt8nRn9r0B8Z2l6Gl0gTrh7CI4V2l4R5oidro4tBSDbqi5b_fGzgdraN7y3vs70zcqs82nqdo-fwrA8X2bjj7wt4UNS78LhrIHmzC09O-9L4S7CHLRgEvpFdtVDSNONsVrKqa0Pyx7Hf1WLVMFp5ZY5Ryl-w87Mxm8-mN7Q0hbcnPCzI_DE3nfKq5rO6YHOMr6-r8Aoujg5_To553z2Bey31kqdlSIQ2eYkZUJr7zMdxkQaM8IIrVY6ZhCcoeI8ai3qdxD4tE-Exuck9qqRUmXgNOzV-5g0wr_JM5pkvQhGkd2rkAiZCsTcYv5WxdhHE68m1vocWpw4XU9umGEbbjh8W-WGJH1ZF8GXzyLzD1fgf8UfimCW8ipo2xFy5VdPYkx_ndqwoAsG00UTwuScqZ_hx7_rzBfgLBHE1oNwfUKJC-cHwh7VgWBqiXWh1gUyxicZ41KRSybtpBLoQnWVqFEew1wnT5gcxd6Sys4ggG4jZhoCwvocjdfWrxfyWmMhm8SiCr2uBtL2xae6et7f3on4HT9NWYTRP033YWS5WxQFGXMv8fatrfwGktyGV
  priority: 102
  providerName: Springer Nature
Title Efficient generation of influenza virus with a mouse RNA polymerase I-driven all-in-one plasmid
URI https://link.springer.com/article/10.1186/s12985-015-0321-5
https://www.ncbi.nlm.nih.gov/pubmed/26093583
https://www.proquest.com/docview/1695182454
https://www.proquest.com/docview/3153677590
https://pubmed.ncbi.nlm.nih.gov/PMC4495709
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ri9NAEF_ugeIX0fMVPcsqgqBE89hH-kGklh53hSvSs9Bvy2Y3OQu9tNeHWP96ZzZJMeXqhxLanTTJzszOzM7kN4S8s9jWKA5jP2bc-ixmoHNCp76wOg1tEuZZgu8OXw7E-Yj1x3x8QOr2VtUELu8M7bCf1Ggx_fT7dvMVFP6LU_hEfF6CzUqwBA0-cRT6_JAcu3QRVvKxbVIBHBXZrhKbd56GwMDCJQbjhpXaXav_MVa7hZQ72VRnpM4ekYeVd0k7pTg8JgdZcULulf0mNyfk_mWVSX9CVM9hR8A_0muHPI0MorOcTsquJX80_TVZrJcUN2qpprhDkNHhoEPns-kGd7Lg64VvF7haUj2d-pPCnxUZnYM7fjOxT8norPeje-5XzRZ8I5hY-VFuw1gkaQ4BU5QaaYIgiyw4hFbnPIXAwyByvAEFh2UgDEyUh7GBWCg1oMGMy_gZOSrgMi8INTyVLJUms5llRvO2thA3BSYBdy8PhPZIUE-uMhUSOTbEmCoXkSRClaxRwBqFrFHcIx-2p8xLGI7_Eb9FjimEtyiwfuZar5dLdXE1VB2ODgtEmYlH3ldE-QwubnT1OgI8AiJiNShPG5Sgf6Yx_KYWDIVDWLRWZMAUFQpwX5OIcbafJgaLI6Tk7cAjz0th2j5gLYwekQ0x2xIgNHhzpJj8dBDhDOJeGbQ98rEWSFWr1v55e7n3Dl6RB5HTE-FH0Sk5Wi3W2WtwxlZpixzKsWyR406nf9WH47fe4PsQfu2KbsttcLScEv4FNfEx0g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9MwED7BEIwXBANGYIBBSEggiyT-kfSxqja1sPZhbNLeLMdORqWSVk2LNP567pK0WiqGxEMeIl8Sxefz3eezvwP44KmskYgEF1J5LoVEm9M249rbLPJpVOQpnR0eT_TwQn69VJctWTSdhbmZv49S_aVCf5TS9jK8RBxxdRfuUeKSaPIHerCZdDEISXpt0vKvj3Xczu7ke8P77O6M3EmP1l7n5DE8asNF1m_0-wTu5OUB3G8KSF4fwINxmxp_Cua4JoPAN7KrmkqaepzNCzZtypD8tuzXdLmuGK28MssI8ufsbNJni_nsmpam8HbE_ZKmP2ZnMz4t-bzM2QLj659T_wwuTo7PB0PeVk_gTku94nHhI6HTrEAEFGcucWGYxx4jPG8LlSGScEQF79Bi0a6j0MVFJByCm8yhSUqViOewV-JnXgBzKktklrjc5146q3rWIxAKXYrxWxFqG0C46VzjWmpxqnAxMzXESLVp9GFQH4b0YVQAn7aPLBpejX8JvyeNGeKrKGlDzJVdV5UZfT8zfUURCMLGNICPrVAxx487254vwF8giquO5FFHEg3KdZrfbQaGoSbahVbmqBQTaYxH01gqebuMQBeik0T1wgAOm8G0_UHEjpR2FgEknWG2FSCu725LOf1Rc35LBLJJ2Avg82ZAmnayqW7vt5f_Jf0W9ofn41NzOpp8ewUP49p4NI_jI9hbLdf5a4y-Vtmb2u7-AGuQJIQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgExMvCMZXxgCDkJBA1vJhO85jBKvWwiq0MWlvlmMnI1KXVk2LNP567vJRkYoh8dCHyJdGyfl89_Odf0fIO4dtjaIgYhEXjvGIg81JkzHpTBY4FRS5wrPDp1N5csEnl-Ky63Na99XufUqyPdOALE3V6mjhitbElTyqwUspLDqDXxQGTNwlu0okCaCv3TSdnE_6xRiCkzjpkpl_vXHgjrYX5T-80nbF5FbatPFGo4fkQRdG0rTV-yNyJ6_2yb22seTNPtk77VLmj4k-bkgi4B_pVUMxjZqg84KWbXuSX4b-LJfrmuKOLDUUtwJyejZN6WI-u8EtK7gcM7fEZZGa2YyVFZtXOV1A3H1duifkYnT8_dMJ67oqMCu5XLGwcEEkVVYAMgozG1vfz0MHkZ8zhcgAYVikiLdgyWDvgW_DIogsgJ7MgqlyEUdPyU4Fj3lOqBVZzLPY5i533BqRGAcAybcK4rrCl8Yjfv9xte0ox7HzxUw30ENJ3epDgz406kMLj3zY3LJo-Tb-JfwWNaaRx6LCQpkrs65rPT4_06nAyATgpPLI-06omMPDrenOHcArIPXVQPJwIAmGZgfDb_qJoXEIq9OqHJSiAwlxqgq54LfLROBaZByLxPfIs3YybV4QMCWmoyOPxINpthFADvDhSFX-aLjAOQDc2E888rGfkLpbhOrbv9vBf0m_JnvfPo_01_H0ywtyP2xsR7IwPCQ7q-U6fwlB2Sp71Rneb9KMLkI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficient+generation+of+influenza+virus+with+a+mouse+RNA+polymerase+I-driven+all-in-one+plasmid&rft.jtitle=Virology+journal&rft.au=Zhang%2C+Xiangmin&rft.au=Curtiss%2C+3rd%2C+Roy&rft.date=2015-06-22&rft.eissn=1743-422X&rft.volume=12&rft.spage=95&rft_id=info:doi/10.1186%2Fs12985-015-0321-5&rft_id=info%3Apmid%2F26093583&rft.externalDocID=26093583
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon